Shanghai Kehua Bio-Engineering Co.,Ltd (SHE:002022)
5.99
-0.05 (-0.83%)
Sep 29, 2026, 10:50 AM CST
SHE:002022 Revenue
Shanghai Kehua Bio-Engineering Co.,Ltd had revenue of 442.42M CNY in the quarter ending June 30, 2026, with 9.05% growth. This brings the company's revenue in the last twelve months to 1.69B, up 2.57% year-over-year. In the year 2025, Shanghai Kehua Bio-Engineering Co.,Ltd had annual revenue of 1.64B, down -6.63%.
Revenue (ttm)
1.69B
Revenue Growth
+2.57%
P/S Ratio
1.79
Revenue / Employee
901.83K
Employees
1,870
Market Cap
3.02B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.64B | -116.71M | -6.63% |
| Dec 31, 2024 | 1.76B | -668.88M | -27.55% |
| Dec 31, 2023 | 2.43B | -4.54B | -65.16% |
| Dec 31, 2022 | 6.97B | 2.12B | 43.58% |
| Jan 1, 2022 | 4.85B | 698.88M | 16.82% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Chison Medical Technologies | 441.10M |
| Tellgen | 392.11M |
| Jiangsu Canopus Wisdom Medical Technology | 384.50M |
| Nanjing Medlander Medical Technology | 383.30M |
| Zhejiang Tailin BioEngineering Co.,Ltd | 359.10M |
| CareRay Digital Medical Technology | 319.79M |
| Beijing Leadman Biochemistry | 317.79M |
| Wuhan Easy Diagnosis Biomedicine | 267.22M |